AVEO Pharma (AVEO) Says Ficlatuzumab and Gefitinib Phase 2 Did Not Show Statistical Significance
Go back to AVEO Pharma (AVEO) Says Ficlatuzumab and Gefitinib Phase 2 Did Not Show Statistical Significance| AVEO PHARMA (NASDAQ: AVEO) | Delayed: 15.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.00 | 52 Week High | $1.42 | |||
| Open | $29.63 | 52 Week Low | $0.56 | |||
| Day High | $15.00 | P/E | N/A | |||
| Day Low | $15.00 | EPS | $-2.28 | |||
| Volume | 4,180,688 | |||||
